tetraphenylphosphonium has been researched along with Ovarian Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albright, KD; Andrews, PA | 1 |
Andrews, PA; Zinkewich-PĂ©otti, K | 1 |
2 other study(ies) available for tetraphenylphosphonium and Ovarian Neoplasms
Article | Year |
---|---|
Mitochondrial defects in cis-diamminedichloroplatinum(II)-resistant human ovarian carcinoma cells.
Topics: Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cell Line; Cell Membrane; Cisplatin; Drug Resistance; Female; Fluorescent Dyes; Humans; Kinetics; Membrane Potentials; Microscopy, Electron; Microscopy, Fluorescence; Mitochondria; Nigericin; Onium Compounds; Organophosphorus Compounds; Ovarian Neoplasms; Rhodamine 123; Rhodamines | 1992 |
Loss of cis-diamminedichloroplatinum(II) resistance in human ovarian carcinoma cells selected for rhodamine 123 resistance.
Topics: Cadmium; Cadmium Chloride; Cell Line; Cisplatin; Doxorubicin; Drug Resistance; Female; Flow Cytometry; Fluorescent Dyes; Glutathione; Humans; Kinetics; Onium Compounds; Organophosphorus Compounds; Ovarian Neoplasms; Rhodamine 123; Rhodamines | 1992 |